Bridging the Treatment Gap by Expanding Access to Care for People With Epilepsy in Kenya (BEACON)
NCT06623994 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 650
Last updated 2026-05-15
Summary
This cluster randomized trial aims to learn about the effectiveness of task-sharing supported by an epilepsy medical records system (EMRS) (hereafter referred to as BEACON) with patient-tracking data in improving treatment adherence and retention in care in people with epilepsy in western Kenya.
Conditions
Interventions
- BEHAVIORAL
-
Task sharing with Epilepsy Medical Record Systems
Training multiple cadres of healthcare workers in epilepsy treatment and management to enable a team-based approach to address access to care. Task sharing will be supported by epilepsy medical records system with patient tracking data to support care retention
Sponsors & Collaborators
-
National Institute of Neurological Disorders and Stroke (NINDS)
collaborator NIH -
Indiana University
lead OTHER
Principal Investigators
-
Jane von Gaudecker, PhD · Indiana University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 12 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-08-04
- Primary Completion
- 2028-02-29
- Completion
- 2028-10-31
Countries
- Kenya
Study Locations
More Related Trials
-
An Open-Label Extension Study of the Effectiveness and Safety of the Investigational Compound RWJ-333369 in Patients With Epilepsy
NCT00210522 ·Status: COMPLETED ·Phase: PHASE2
-
Cannabis Extract in Refractory Epilepsy Study
NCT03808935 ·Status: TERMINATED ·Phase: PHASE3
-
Investigating Epilepsy: Screening and Evaluation
NCT03478852 ·Status: RECRUITING
-
Cannabidiol for Drug Resistant Pediatric Epilepsy (Expanded Access Use)
NCT03676049 ·Status: AVAILABLE
-
Enhancing Medical Compliance and Health-related Quality of Life of Patients With Epilepsy
NCT02547389 ·Status: COMPLETED ·Phase: NA
-
Add-on Therapy With Low Dose Fenfluramine in Lennox Gastaut Epilepsy
NCT02655198 ·Status: UNKNOWN ·Phase: PHASE2
-
Cognitive Enhancement Intervention for Creating a Healthy L.I.F.E (Lifestyle Interventions for Epilepsy)
NCT05954182 ·Status: RECRUITING ·Phase: NA
-
Epidiolex and Drug Resistant Epilepsy in Children
NCT02397863 ·Status: AVAILABLE
-
Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy
NCT06309966 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
A Study of the Efficacy and Safety of RWJ-333369 as add-on Therapy in the Treatment of Partial Onset Seizures.
NCT00425282 ·Status: COMPLETED ·Phase: PHASE3
-
Retigabine Efficacy and Safety Trial for Partial Onset Refractory Seizures in Epilepsy
NCT00235755 ·Status: COMPLETED ·Phase: PHASE3
-
Cannabidiol (CBD) to 27 Patients (Aged 2 Years - 19 Years) With Drug Resistant Epilepsy
NCT02286986 ·Status: COMPLETED ·Phase: PHASE1
-
Enhancing Antiepileptic Drug Adherence
NCT02165306 ·Status: COMPLETED ·Phase: NA
-
Cannabidiol in Children and Young Adults With Rare Disease-associated Severe Epilepsy
NCT05803434 ·Status: UNKNOWN ·Phase: PHASE2
-
Study to Look at How Effective Briviact is as add-on Treatment for Patients With Epilepsy With Partial Onset Seizures
NCT02687711 ·Status: COMPLETED
-
A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P; CBD) as Adjunctive Treatment for Seizures Associated With Lennox-Gastaut Syndrome in Children and Adults
NCT02224690 ·Status: COMPLETED ·Phase: PHASE3
-
Behavioral and Educational Tools to Improve Epilepsy Care
NCT02646631 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Ketogenic Diet as Adjunctive Treatment in Adults With Refractory Epilepsy
NCT01906398 ·Status: UNKNOWN ·Phase: PHASE2
-
Epidiolex in Typical Absence Seizures
NCT04899050 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Assess utiLity of BIoEP as an Early Prognostic Indicator for Predicting Anti-Seizure Medication (ASM) Efficacy
NCT06354868 ·Status: NOT_YET_RECRUITING
-
An Open-Label Extension Study to Evaluate the Safety and Effectiveness of RWJ 333369 in Patients With Epilepsy
NCT00210652 ·Status: COMPLETED ·Phase: PHASE2
-
A Double-Blind Trial to Evaluate Efficacy and Safety of Cannabidiol as an add-on Therapy for Treatment in Refractory Epilepsy
NCT02783092 ·Status: UNKNOWN ·Phase: PHASE3
-
Safety and Tolerability of Cannabidiol in Subjects With Drug Resistant Epilepsy
NCT02660255 ·Status: APPROVED_FOR_MARKETING
-
Efficacy and Safety of YKP3089 in Subjects With Treatment Resistant Partial Onset Seizures
NCT01397968 ·Status: COMPLETED ·Phase: PHASE2
-
Retigabine (Adjunctive Therapy) Efficacy and Safety Study for Partial Onset Refractory Seizures in Epilepsy
NCT00232596 ·Status: COMPLETED ·Phase: PHASE3